Hepatitis: Screening and Testing Methods

 

<p justify;"="" style="text-align: justify;">The disclosure of hepatitis infection (HV) has prompted the advancement of serological tests for the discovery of counteracting agent to this newfound infection. Gatherings at more serious danger of obtaining HV contamination incorporate intravenous medication clients, haemodialysis patients, haemophiliacs and blood transfusion beneficiaries. The screening of blood givers for hostile to HV has incredibly diminished the rate of post-transfusion hepatitis. One of the real issues with HV disease is the advancement of endless hepatitis in 50 to 60% of cases, which could prompt cirrhosis and hepatocellular carcinoma.

 

  • Serological assays for detection of HV infection
  • Molecular assays for the detection of HV infection
  • Quantitation of HV RNA
  • Genotyping of HV isolates

Related Conference of Hepatitis: Screening and Testing Methods

March 18-19, 2020

International Conference on Gastroenterology and Liver

Amsterdam, Netherlands
March 18-19, 2020

11th International conference on Liver and Hepatitis

Amsterdam, Netherlands
30-31 March 2020

7th International Conference on Hepatology

Osaka, Japan
June 24-25, 2020

15th Euro-Global Gastroenterology Conference

Rome, Italy
July 20-21, 2020

20th World Gastroenterologists Summit

Osaka, Japan
September 28-29. 2020

3rd World Liver Congress

Abu Dhabi, UAE
November 16-17, 2020

30th World Congress on Nursing

Brisbane, Australia
07-08 December, 2020 |

International Congress on Gastroenterology and Liver Transplant

Auckland, Newzeland

Hepatitis: Screening and Testing Methods Conference Speakers

Recommended Sessions

Related Journals

Are you interested in